<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8754418</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cabrera Chaves, T</dc:author>
<dc:author>Simón Marco, M A</dc:author>
<dc:author>Uribarrena Echebarría, R</dc:author>
<dc:author>Botella Esteban, M T</dc:author>
<dc:author>Gomollón García, F</dc:author>
<dc:description xml:lang="en">Five patients with hepatitis C virus infection of different severity and evolution following the administration of intravenous (i.v.) immunoglobulins (Igs) are presented. The important morbidity of hepatitis C virus infection and the need for adequate donor screening are discussed, as is accurate indication of these drugs in the management of patients with immunosuppression and other diseases.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>1996 Jun-Jul </dc:date>
<dc:title xml:lang="es">Hepatitis C tras administración de inmunoglobulinas intravenosas.</dc:title>
<dc:title xml:lang="en">[Hepatitis C following administration of intravenous immunoglobulins].</dc:title>
<dc:publisher>Gastroenterologia y hepatologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
